- Display 15 Products per page
Published: April 7, 2020 | Price: $750.00 – $1,000.00
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...Published: October 26, 2020 | Price: $3,000.00 – $6,000.00
The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently. In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths. Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals. This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...Published: March 12, 2021 | Price: $3,000.00 – $6,000.00
What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...Published: April 15, 2021 | Price: $3,000.00 – $6,000.00
This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or...Published: September 29, 2021 | Price: $3,000.00 – $6,000.00
A considerable number of diagnostic tests are available or in development for the detection of autoimmune diseases. Because of this potentially large and growing market, vast opportunity exists for discovery and advancement in this arena. Competition within this market is expected to increase dramatically. However, in fledgling autoimmune IVD diagnostic testing markets, a golden opportunity exists to capitalize on new testing innovations without significant competition. In terms of test options, a substantial amount of overlap exists in the various autoimmune...Published: September 29, 2021 | Price: $3,000.00 – $6,000.00
Allergies are a number of conditions that are caused by hypersensitivity to a substance in the environment. Allergies can run the gamut of seasonal nuisances to life-threatening ordeals. Allergy statistics show that these conditions are constantly present in lives and are not going away. Factors contributing to allergies worldwide include: Environmental pollution Changing lifestyles and dietary patterns Indoor pollution An individual who is overly reactive to an antigen that is tolerated by most others is said to be hypersensitive (allergic). ...Published: January 5, 2022 | Price: $3,750.00 – $7,500.00
This new Kalorama Information report, World Market for Blood Screening, focuses on the evolving, multibillion dollar global blood screening market. Blood screening is a medical process that scans the blood for infectious diseases or conditions. In developed nations, donated blood is screened for various pathogens. It is a mature market; however, growth comes from new technologies, increased volume and increased testing in developing nations. Blood screening testing’s primary objectives are to monitor the appearance of newly discovered infectious agents in...Published: March 29, 2022 | Price: $3,750.00 – $7,500.00
The at-home IVD testing market is a growing market with much potential. This report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), analyzes at-home tests where the entire process is done at home. A sample is collected, and the results are provided in under one hour. This does not include self-collection at home and then sent to a laboratory where it can be analyzed. This report is segmented into three areas: Glucose Infectious disease Other...Published: April 19, 2022 | Price: $3,750.00 – $7,500.00
This report, COVID-19 Testing Market Update, 2022, provides market sizing and estimates for COVID-19 tests with some discussion of market impacts of COVID-19. The scourge of COVID-19 continued to occupy laboratories and the in vitro diagnostic (IVD) companies that serve them throughout 2021 and into 2022. Testing already present in large labs and clinics entered the home last year, which added to market revenues. There was 33 BN of revenues in 2021, and the report details the share of antigen,...Published: March 17, 2023 | Price: $3,750.00 – $7,500.00
Diagnostic testing continues to be a valuable resource to help physicians arrive at a diagnosis. Additionally, it has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. Now, in the aftermath of the COVID-19 pandemic, new products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient. Ultimately, the...Published: November 7, 2023 | Price: $3,750.00 – $7,500.00
In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors...Published: December 19, 2023 | Price: $3,750.00 – $7,500.00
Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...Published: May 14, 2020 | Price: $4,000.00 – $8,000.00
CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...Published: November 2, 2020 | Price: $4,000.00 – $8,000.00
COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...Published: November 4, 2020 | Price: $4,000.00 – $8,000.00
Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information's report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET INFORMATION The vaccine market is a growth market for the experienced competitors participating in it.Seven billion dollars in new sales have occurred in the past...